Búsqueda | Portal de Búsqueda de la BVS España

1.

Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.

Kuter, David J; Rogers, Kerry A; Boxer, Michael A; Choi, Michael; Agajanian, Richy; Arnold, Donald M; Broome, Catherine M; Field, Joshua J; Murakhovskaya, Irina; Numerof, Robert; Tong, Sandra.

Am J Hematol; 97(6): 691-699, 2022 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-35179251

2.

Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia.

Boccia, Ralph; Cooper, Nichola; Ghanima, Waleed; Boxer, Michael A; Hill, Quentin A; Sholzberg, Michelle; Tarantino, Michael D; Todd, Leslie K; Tong, Sandra; Bussel, James B.

Br J Haematol; 190(6): 933-938, 2020 09.

Artículo en Inglés | MEDLINE | ID: mdl-33439486

3.

Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.

Bussel, James B; Arnold, Donald M; Boxer, Michael A; Cooper, Nichola; Mayer, Jiri; Zayed, Hany; Tong, Sandra; Duliege, Anne-Marie.

Am J Hematol; 94(5): 546-553, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30784097

4.

Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia.

Byrd, John C; Flynn, Joseph M; Kipps, Thomas J; Boxer, Michael; Kolibaba, Kathryn S; Carlile, David J; Fingerle-Rowson, Guenter; Tyson, Nicola; Hirata, Jamie; Sharman, Jeff P.

Blood; 127(1): 79-86, 2016 Jan 07.

Artículo en Inglés | MEDLINE | ID: mdl-26472752

5.

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia.

Sharman, Jeff; Hawkins, Michael; Kolibaba, Kathryn; Boxer, Michael; Klein, Leonard; Wu, Meihua; Hu, Jing; Abella, Steve; Yasenchak, Chris.

Blood; 125(15): 2336-43, 2015 Apr 09.

Artículo en Inglés | MEDLINE | ID: mdl-25696919

6.

Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.

Scherber, Robyn M; Kosiorek, Heidi E; Senyak, Zhenya; Dueck, Amylou C; Clark, Matthew M; Boxer, Michael A; Geyer, Holly L; McCallister, Archie; Cotter, Mary; Van Husen, Barbara; Harrison, Claire N; Mesa, Ruben A.

Cancer; 122(3): 477-85, 2016 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-26670597

7.

Reflections on 45 years as a clinical hematologist.

Boxer, Michael.

Clin Adv Hematol Oncol; 18(3): 160-161, 2020 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-32609665

8.

Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab.

Treon, Steven P; Soumerai, Jacob D; Hunter, Zachary R; Patterson, Christopher J; Ioakimidis, Leukothea; Kahl, Brad; Boxer, Michael.

Blood; 118(2): 276-81, 2011 Jul 14.

Artículo en Inglés | MEDLINE | ID: mdl-21566092

9.

Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine.

Danilov, Alexey V; Yimer, Habte A; Boxer, Michael A; Burke, John M; Babu, Sunil; Li, Jia; Mun, Yong; Trask, Peter C; Masaquel, Anthony S; Sharman, Jeff P.

Clin Lymphoma Myeloma Leuk; 22(2): 121-128, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-34674981

10.

Phase 2, multicenter GIBB study of obinutuzumab plus bendamustine in previously untreated patients with chronic lymphocytic leukemia.

Sharman, Jeff P; Burke, John M; Yimer, Habte A; Boxer, Michael A; Babu, Sunil; Li, Jia; Mun, Yong; Danilov, Alexey V.

Leuk Lymphoma; 62(4): 791-800, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33243049

11.

The risk of Parkinson's disease in type 1 Gaucher disease.

Bultron, Gilberto; Kacena, Katherine; Pearson, Daniel; Boxer, Michael; Yang, Ruhua; Sathe, Swati; Pastores, Gregory; Mistry, Pramod K.

J Inherit Metab Dis; 33(2): 167-73, 2010 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-20177787

12.

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors.

Boxer, Michael.

EJHaem; 1(2): 548-551, 2020 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-35845020

13.

Etiologies of Thrombocytopenia in the Community Hospital: The Experience of 1 Hematologist.

Boxer, Michael; Biuso, Thomas J.

Am J Med; 133(5): e183-e186, 2020 05.

Artículo en Inglés | MEDLINE | ID: mdl-31712096

14.

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition.

Padrnos, Leslie; Scherber, Robyn; Geyer, Holly; Langlais, Blake T; Dueck, Amylou C; Kosiorek, Heidi E; Senyak, Zhenya; Clark, Matthew; Boxer, Michael; Cotter, Mary; Harrison, Claire; Stonnington, Cynthia; Geda, Yonas; Mesa, Ruben.

Cancer Med; 9(22): 8301-8309, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32976697

15.

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.

Taddei, Tamar H; Kacena, Katherine A; Yang, Mei; Yang, Ruhua; Malhotra, Advitya; Boxer, Michael; Aleck, Kirk A; Rennert, Gadi; Pastores, Gregory M; Mistry, Pramod K.

Am J Hematol; 84(4): 208-14, 2009 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-19260119

16.

Collateral Damages by Magic Bullets: Hemolytic Uremic and Capillary Leak Syndromes After Moxetumomab Pasudotox Therapy.

Lien, Yeong-Hau H; Boxer, Michael.

Am J Med; 132(12): e846-e847, 2019 12.

Artículo en Inglés | MEDLINE | ID: mdl-31233704

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: